Skip to content

The Influence of Two Different CO2 Absorbers on Sevoflurane Consumption During Anaesthesia

The Influence of Two Different CO2 Absorbers on Sevoflurane Consumption During Anaesthesia

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04271462
Enrollment
38
Registered
2020-02-17
Start date
2020-02-12
Completion date
2020-05-29
Last updated
2021-02-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anesthesia

Brief summary

Traditional sodalime CO2 absorbers are known to not only react with CO2 but also with sevoflurane. Therewith, a potentially harmful compound (compound A) is formed that can be nephrotoxic. In the United States, the sevoflurane manufacturer therefore recommends keeping the FGF (FGF) at \>2.0 L min-1 if a sodalime CO2 absorbent is used. Amsorb Plus® (Datex-Ohmeda Inc., Madison, WI, USA), is a novel type of CO2 absorbent that does not react with sevoflurane. This allows the FGF to be reduced to 0.5 L min-1. This has two important advantages: (i) less fresh sevoflurane is added to the circle system, and (ii) the sevoflurane that is in the system does not react with the CO2 absorber. Sevoflurane is a potent greenhouse gas with a 100 year CO2-equivalents of 120. Measures that can reduce the consumption of volatile anaesthetics could make a significant contribution to reducing the carbon footprint of the operative process. Additionally, Amsorb Plus® canisters seem to have a longer life span than sodalime canisters and do not need to be disposed of via toxic waste stream, but via domestic waste. In this study, we were interested if (i) the use of Amsorb Plus leads to a reduction in sevoflurane usage and therefore contribute to a reduction in the CO2 footprint of general anaesthesia with sevoflurane, (ii) Does the use of Amsorb Plus® lead to a reduction in the amount of (toxic) waste produced by operating theatres? Comparator: a traditional sodalime CO2 absorber (Medisorb™ Multi-Absorber Original, CareFusion, Helsinki, Finland).

Interventions

OTHERComparing two CO2 absorbers in the ventilator circuit

General anaesthesia will be induced with a standardised regimen (propofol 0.8-2.5 mg·kg-1, sufentanil 0.2 - 0.5 µg·kg-1 and rocuronium 0.5 - 1 mg·kg-1). After tracheal intubation, anaesthesia will be maintained with sevoflurane targeted at 1 MAC end tidal concentration (corrected for age using the formula by Mapleson) in 40% O2. Different ventilator settings will be compared for 30 minutes (in randomised order): I. Sodalime, FGF 2.0 L min-1. II. Amsorb Plus®, FGF 2.0 L min-1. III. Soda lime, FGF, 0.5 L min-1. IV. Amsorb Plus®, FGF 0.5 L min-1. FGF=fresh gas flow.

Sponsors

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Lead SponsorOTHER

Study design

Observational model
CASE_CROSSOVER
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 100 Years
Healthy volunteers
No

Inclusion criteria

* Adult patient * non-pregnant * ASA-I to ASA-III * undergoing Sevoflurane based general anaesthesia (in a therapeutic concentration of 1.0 MAC) * Elective surgery * Scheduled operating time \>2 hours.

Exclusion criteria

* Unable/ unwilling to participate * ASA-IV or higher * Age \< 18 years * Known pregnancy * Contra-indications for sevoflurane anaesthesia * Emergency surgery * Scheduled operating time \<2 hours.

Design outcomes

Primary

MeasureTime frameDescription
Influence of CO2 filters on Sevoflurane consumption30 minutes per filterComparing Sevoflurane consumption between Amsorb Plus and sodalime CO2 absorbers

Secondary

MeasureTime frameDescription
Influence of fresh gas flow on Sevoflurane consumption30 minutes per fresh gas flow settingComparing Sevoflurane consumption between 0.5 and 2.0 liters per minute fresh gas flow

Other

MeasureTime frameDescription
Estimated CO2 footprint and environmental impact of general anaesthesia with two different CO2 filters30 minutesEstimate the CO2 footprint and environmental impact of general anaesthesia with sevoflurane comparing two different CO2 filters using life cycle analysis methods.
Estimated cost of general anaesthesia with two different CO2 filters30 minutesEstimate the total cost of general anaesthesia with sevoflurane comparing two different CO2 filters using life cycle analysis methods.
Estimated CO2 footprint and environmental impact of general anaesthesia with two fresh gas flow settings30 minutesEstimate the CO2 footprint of general anaesthesia with sevoflurane comparing two different fresh gas flow settings using life cycle analysis methods.
Estimated cost of general anaesthesia with two fresh gas flow settings30 minutesEstimate the total cost of general anaesthesia with sevoflurane comparing two different fresh gas flow settings.

Countries

Netherlands

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026